AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Inovalis Real Estate Investment Trust

$0.6 -$0.13 (-17.65%)
OTC · 14 Sep 2026 20:00 UTC
Previous Close
$0.6
Day Range
$0.53$0.6
Year Range
$0.51$0.8
Market Cap
20.02M
AVG Volume
702
Trailing/Forward PE
-0.55/-
PEG ratio
0.01
Dividend Yield
6.11%
Next Earnings Date
2026-11-12
Primary Exchange
Other OTCUS
Revenue (CAD)
010M20M30M40M2016201720182019202020212022202320242025
IVREF Revenue (CAD) by year
PeriodRevenue (CAD)
202522.35M
202420.07M
202333.57M
202231.14M
202134.49M
202035.84M
201933.94M
201833.48M
201732.55M
201631.12M
Net Income (CAD)
-100M-50M050M2016201720182019202020212022202320242025
IVREF Net Income (CAD) by year
PeriodNet Income (CAD)
2025-55.94M
2024-69.13M
2023-29.69M
2022-36.85M
202130.33M
202018.2M
201936.45M
201822.15M
201719.17M
201623.29M
Operating Income (CAD)
020M40M60M2016201720182019202020212022202320242025
IVREF Operating Income (CAD) by year
PeriodOperating Income (CAD)
20253.32M
20241.01M
20232.85M
202210.02M
20215.02M
20207.45M
201944.89M
201825.68M
201721.98M
201631.25M
EBITDA (CAD)
-50M-25M025M50M2016201720182019202020212022202320242025
IVREF EBITDA (CAD) by year
PeriodEBITDA (CAD)
2025-41.74M
2024-30.66M
20234.67M
202221.59M
202139.88M
202038.37M
201945.9M
201839.38M
201731.57M
201629.23M
Cash Flows (CAD)
-20M020M40M60M2016201720182019202020212022202320242025
IVREF Cash Flows (CAD) by year
PeriodCash Flows (CAD)
2025-4.82M
2024913K
20233.97M
202221.43M
2021-7.92M
2020-2.67M
201923.67M
201820.58M
201759.38M
201617.61M
EPS (CAD)
-3-2-10122016201720182019202020212022202320242025
IVREF EPS (CAD) by year
PeriodEPS (CAD)
2025-1.68
2024-2.13
2023-0.91
2022-1.13
20210.94
20200.65
20191.31
20180.95
20170.87
20161.14
Expenses (CAD)
-40M-20M020MSG&ACapex2016201720182019202020212022202320242025
IVREF Expenses (CAD) by year
PeriodExpenses (CAD)
20254.85M
20245.7M
20236.05M
20226.49M
202111.57M
20207.79M
20196.14M
20184.79M
2017-26.54M
20165.15M
Cash & Debt (CAD)
050M100M150M200MCashLong Term DebtShort Term Debt2016201720182019202020212022202320242025
IVREF Cash & Debt (CAD) by year
PeriodCash & Debt (CAD)
202525.41M
20246.25M
202312.49M
202245.18M
202176.63M
202080.38M
201983.41M
201819.11M
201721.61M
201638.98M
Debt ratios
-5-2.502.557.520182019202020212022202320242025
IVREF Debt ratios by year
PeriodDebt ratios
2025-3.88
20245.9
20231.98
20221.36
20210.8
20201.34
20191.54
20181.86
Margins
0%20%40%60%80%2016201720182019202020212022202320242025
IVREF Margins by year
PeriodMargins
202541.24%
202448.51%
202369.17%
202269.46%
202170.13%
202074.42%
201967.73%
201870.26%
201773.71%
201671.92%
Return on Capital
-60%-40%-20%0%20%2016201720182019202020212022202320242025
IVREF Return on Capital by year
PeriodReturn on Capital
2025-40.67%
2024-37.96%
2023-12%
2022-12.79%
20218.76%
20204.83%
201910.94%
20187.58%
20177.23%
20169.66%
Shares Outstanding
010M20M30M40M2016201720182019202020212022202320242025
IVREF Shares Outstanding by year
PeriodShares Outstanding
202524.25M
202432.59M
202332.58M
202232.78M
202132.51M
202030.77M
201928.74M
201823.34M
201721.78M
201619.19M
Dividends (CAD)
00.250.50.7512015201620172018201920202021202220232025
IVREF Dividends (CAD) by year
PeriodDividends (CAD)
20250.03
20230.28
20220.53
20210.91
20200.61
20190.62
20180.63
20170.64
20160.62
20150.64
Book Value Per Share (CAD)
0510152016201720182019202020212022202320242025
IVREF Book Value Per Share (CAD) by year
PeriodBook Value Per Share (CAD)
20255.67
20245.59
20237.59
20228.79
202110.65
202012.24
201911.59
201812.52
201712.18
201612.57
Total Assets (CAD)
0200M400M600M800M2016201720182019202020212022202320242025
IVREF Total Assets (CAD) by year
PeriodTotal Assets (CAD)
2025363.08M
2024412.22M
2023484.06M
2022561.11M
2021587.25M
2020712.09M
2019710.21M
2018619.34M
2017576.71M
2016510.12M
PE Ratio
010203040med 8.67Dec 20Apr 21Oct 21Feb 22May 22Sep 22Dec 22
IVREF PE Ratio by year
PeriodPE Ratio
Dec 2222.32
Dec 2222.5
Dec 2221.84
Dec 2221.5
Nov 2220.09
Nov 2220.1
Nov 2222.43
Nov 2222.36
Oct 2222.56
Oct 2223.2
Oct 2222.59
Oct 2222.35
Sep 2222.5
Sep 225.09
Sep 225.35
Sep 225
Sep 225.08
Aug 225.66
Aug 225.99
Aug 228.31
Aug 228.26
Jul 228.29
Jul 228.28
Jul 228.25
Jul 228.29
Jul 228.61
Jun 227.89
Jun 227.69
Jun 228.25
Jun 228.39
May 228.4
May 228.69
May 228.14
May 228.65
Apr 229.07
Apr 229.45
Apr 229.58
Apr 229.79
Apr 229.91
Mar 228.1
Mar 228.64
Mar 228.34
Mar 229.05
Feb 229.04
Feb 229.15
Feb 229.03
Feb 228.82
Jan 228.55
Jan 228.57
Jan 228.63
Jan 228.6
Dec 218.24
Dec 2134.33
Dec 2134.19
Dec 2133.74
Dec 2133.66
Nov 2135.26
Nov 2134.71
Nov 2134.88
Nov 2134.79
Oct 2134.77
Oct 2135.09
Oct 2134.34
Oct 2134.69
Oct 2134.91
Jun 2116.82
Jun 2117.17
Jun 2117.09
Jun 2116.86
May 2116.79
May 2116.84
May 2116.83
May 2116.89
Apr 2116.92
Apr 2116.54
Apr 2116.73
Apr 2116.54
Apr 2115.89
Mar 214.81
Mar 214.79
Mar 214.77
Mar 214.87
Feb 215.01
Feb 214.68
Feb 214.68
Feb 214.65
Jan 214.46
Jan 214.76
Jan 214.54
Jan 214.52
Dec 204.46
Dec 204.39
Dec 204.37
Dec 204.27
Dec 204.42
Nov 204.25
Nov 204.23
Nov 204.01
Nov 203.84
Oct 203.82
Free Cash Flow Yield
-60%-40%-20%0%20%med -15.4%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
IVREF Free Cash Flow Yield by year
PeriodFree Cash Flow Yield
Sep 26-48.06%
Sep 26-48.06%
Sep 26-48.19%
Aug 26-47.94%
Aug 26-48.43%
Aug 26-48.04%
Aug 26-47.83%
Jul 26-47.57%
Jul 26-47.3%
Jul 26-47.54%
Jul 26-47.1%
Jul 26-47%
Jun 26-23.31%
Jun 26-23.39%
Jun 26-23.64%
Jun 26-23.73%
May 26-23.99%
May 26-23.94%
May 26-24.06%
May 26-24.19%
May 26-22.86%
Apr 26-22.73%
Apr 26-22.69%
Apr 26-22.45%
Apr 26-17.81%
Mar 26-6.91%
Mar 26-7%
Mar 26-7%
Mar 26-7.08%
Feb 26-7.04%
Feb 26-7.02%
Feb 26-7.05%
Feb 26-7.02%
Jan 26-7.05%
Jan 26-7.95%
Jan 26-7.82%
Jan 26-7.62%
Jan 26-7.73%
Dec 25-15.8%
Dec 25-17.22%
Dec 25-18.98%
Dec 25-21.17%
Nov 25-20.94%
Nov 25-20.34%
Nov 25-19.19%
Nov 25-19.49%
Oct 25-19.41%
Oct 25-19.35%
Oct 25-19.31%
Oct 25-19.34%
Oct 25-19.52%
Sep 257.34%
Sep 257.43%
Sep 257.96%
Sep 257.97%
Aug 257.55%
Aug 256.36%
Aug 256.37%
Aug 256.4%
Aug 256.42%
Jul 256.46%
Jul 256.54%
Jul 256.55%
Jul 256.53%
Jun 252.83%
Jun 252.82%
Jun 252.85%
Jun 253.08%
May 253.07%
May 253.07%
May 253.02%
May 253.03%
May 252.98%
Apr 253.33%
Apr 253.34%
Apr 253.04%
Apr 252.96%
Mar 25-15.93%
Mar 25-15.88%
Mar 25-15.86%
Mar 25-15.87%
Feb 25-15.76%
Feb 25-16.03%
Feb 25-16.91%
Feb 25-16.48%
Jan 25-15.86%
Jan 25-16.06%
Jan 25-17.21%
Jan 25-15.42%
Jan 25-15.39%
Dec 246.71%
Dec 246.73%
Dec 247.85%
Dec 247.9%
Nov 247.98%
Nov 248%
Nov 246.65%
Nov 247.01%
Nov 245.56%
Oct 245.58%
Price to Sales
0.811.21.41.61.8med 1.2Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
IVREF Price to Sales by year
PeriodPrice to Sales
Sep 260.97
Sep 260.97
Sep 260.97
Aug 260.98
Aug 260.97
Aug 260.97
Aug 260.98
Jul 260.98
Jul 260.99
Jul 260.98
Jul 260.99
Jul 261
Jun 260.93
Jun 260.92
Jun 260.91
Jun 260.91
May 260.9
May 260.9
May 260.9
May 260.89
May 260.94
Apr 260.95
Apr 260.95
Apr 260.96
Apr 261.21
Mar 261.16
Mar 261.15
Mar 261.15
Mar 261.13
Feb 261.14
Feb 261.14
Feb 261.14
Feb 261.14
Jan 261.14
Jan 261.01
Jan 261.03
Jan 261.05
Jan 261.04
Dec 251.46
Dec 251.34
Dec 251.21
Dec 251.09
Nov 251.1
Nov 251.13
Nov 251.2
Nov 251.18
Oct 251.19
Oct 251.19
Oct 251.19
Oct 251.19
Oct 251.18
Sep 251.36
Sep 251.34
Sep 251.25
Sep 251.25
Aug 251.32
Aug 251.56
Aug 251.56
Aug 251.56
Aug 251.55
Jul 251.54
Jul 251.52
Jul 251.52
Jul 251.52
Jun 251.61
Jun 251.61
Jun 251.59
Jun 251.48
May 251.48
May 251.48
May 251.51
May 251.5
May 251.53
Apr 251.37
Apr 251.36
Apr 251.5
Apr 251.54
Mar 251.5
Mar 251.51
Mar 251.51
Mar 251.51
Feb 251.52
Feb 251.49
Feb 251.41
Feb 251.45
Jan 251.51
Jan 251.49
Jan 251.39
Jan 251.55
Jan 251.55
Dec 241.38
Dec 241.38
Dec 241.18
Dec 241.18
Nov 241.16
Nov 241.16
Nov 241.39
Nov 241.32
Nov 241.67
Oct 241.66
EV/EBITDA
050100150med 19.65Jan 23Apr 23Aug 23Nov 23Mar 24Jun 24Sep 24
IVREF EV/EBITDA by year
PeriodEV/EBITDA
Sep 24117.64
Sep 24118
Sep 24118.02
Sep 24118
Aug 24119.11
Aug 24119.14
Aug 24122.59
Aug 24120.73
Aug 24122.04
Jul 24117.62
Jul 24117.49
Jul 24116.71
Jul 24115.27
Jun 2449.97
Jun 2449.98
Jun 2451.55
Jun 2451.57
May 2451.49
May 2451.48
May 2451.46
May 2451.49
May 2451.81
Apr 2451.8
Apr 2451.84
Apr 2453.33
Apr 2453.22
Mar 2419.51
Mar 2419.66
Mar 2419.64
Mar 2419.72
Mar 2419.73
Feb 2419.65
Feb 2419.67
Feb 2419.75
Feb 2420
Jan 2420.17
Jan 2420.27
Jan 2420.48
Jan 2420.68
Dec 2320.61
Dec 2310.19
Dec 2310.22
Dec 2310.18
Dec 239.66
Nov 239.64
Nov 239.72
Nov 2311.16
Nov 2311.41
Oct 2311.08
Oct 2311.55
Oct 2311.7
Oct 2311.77
Sep 2312.23
Sep 2313.96
Sep 2314.06
Sep 2314.16
Sep 2314.32
Aug 2314.35
Aug 2314.45
Aug 2314.79
Aug 2314.73
Jul 2314.67
Jul 2314.66
Jul 2314.4
Jul 2314.37
Jun 2314.1
Jun 2314.01
Jun 2314.02
Jun 2314.37
Jun 2314.41
May 2314.48
May 2314.13
May 2314.15
May 2313.78
Apr 2314.37
Apr 2314.43
Apr 2314.64
Apr 2314.6
Mar 2314.34
Mar 2326.44
Mar 2327.31
Mar 2327.55
Mar 2328.77
Feb 2328.78
Feb 2329.39
Feb 2328.94
Feb 2329.4
Jan 2329.42
Jan 2328.97
Jan 2328.61
Jan 2327.55
Dec 2227.21
Dec 2211.48
Dec 2211.52
Dec 2211.39
Dec 2211.32
Nov 2211.05
Nov 2211.05
Nov 2211.51
Nov 2211.49
Price/Operating Cashflow
010203040med 7.8Oct 23Jan 24May 24Aug 24Nov 24Jun 25Sep 25
IVREF Price/Operating Cashflow by year
PeriodPrice/Operating Cashflow
Sep 2513.62
Sep 2513.46
Sep 2512.57
Sep 2512.55
Aug 2513.24
Aug 2515.71
Aug 2515.7
Aug 2515.64
Aug 2515.58
Jul 2515.48
Jul 2515.3
Jul 2515.26
Jul 2515.33
Jun 2535.28
Jun 2535.42
Jun 2535.03
Jun 2532.45
May 2532.56
May 2532.54
May 2533.11
May 2533.03
May 2533.53
Apr 2530.01
Apr 2529.97
Apr 2532.91
Apr 2533.77
Dec 2414.91
Dec 2414.86
Dec 2412.73
Dec 2412.66
Nov 2412.53
Nov 2412.5
Nov 2415.03
Nov 2414.27
Nov 2417.98
Oct 2417.91
Oct 2417.79
Oct 2417.74
Oct 2418.27
Sep 245.6
Sep 245.71
Sep 245.72
Sep 245.71
Aug 246.07
Aug 246.08
Aug 247.18
Aug 246.59
Aug 247.01
Jul 245.59
Jul 245.55
Jul 245.3
Jul 244.84
Jun 246.67
Jun 246.67
Jun 248.52
Jun 248.54
May 248.45
May 248.44
May 248.41
May 248.45
May 248.82
Apr 248.81
Apr 248.86
Apr 2410.62
Apr 2410.48
Mar 242.21
Mar 242.31
Mar 242.3
Mar 242.35
Mar 242.36
Feb 242.31
Feb 242.32
Feb 242.37
Feb 242.54
Jan 242.66
Jan 242.73
Jan 242.87
Jan 243
Dec 232.95
Dec 232.58
Dec 232.63
Dec 232.58
Dec 231.93
Nov 231.91
Nov 232
Nov 233.79
Nov 234.11
Oct 233.7
Oct 234.29
Oct 234.47
Oct 234.56
Sep 235.13
Sep 235.5
Sep 235.62
Sep 235.74
Sep 235.93
Aug 235.96
Aug 236.09
Aug 236.49
Aug 236.41
Price to Book
0.10.120.150.170.2med 0.14Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
IVREF Price to Book by year
PeriodPrice to Book
Sep 260.13
Sep 260.13
Sep 260.13
Aug 260.13
Aug 260.13
Aug 260.13
Aug 260.13
Jul 260.13
Jul 260.13
Jul 260.13
Jul 260.13
Jul 260.13
Jun 260.15
Jun 260.15
Jun 260.15
Jun 260.15
May 260.15
May 260.15
May 260.15
May 260.14
May 260.15
Apr 260.15
Apr 260.15
Apr 260.16
Apr 260.2
Mar 260.14
Mar 260.14
Mar 260.14
Mar 260.14
Feb 260.14
Feb 260.14
Feb 260.14
Feb 260.14
Jan 260.14
Jan 260.12
Jan 260.12
Jan 260.13
Jan 260.12
Dec 250.18
Dec 250.16
Dec 250.15
Dec 250.13
Nov 250.13
Nov 250.14
Nov 250.15
Nov 250.14
Oct 250.14
Oct 250.14
Oct 250.14
Oct 250.14
Oct 250.14
Sep 250.14
Sep 250.14
Sep 250.13
Sep 250.13
Aug 250.13
Aug 250.16
Aug 250.16
Aug 250.16
Aug 250.16
Jul 250.16
Jul 250.16
Jul 250.15
Jul 250.16
Jun 250.18
Jun 250.18
Jun 250.18
Jun 250.16
May 250.16
May 250.16
May 250.17
May 250.17
May 250.17
Apr 250.15
Apr 250.15
Apr 250.17
Apr 250.17
Mar 250.15
Mar 250.15
Mar 250.15
Mar 250.15
Feb 250.15
Feb 250.15
Feb 250.14
Feb 250.14
Jan 250.15
Jan 250.15
Jan 250.14
Jan 250.15
Jan 250.15
Dec 240.14
Dec 240.14
Dec 240.12
Dec 240.12
Nov 240.12
Nov 240.12
Nov 240.14
Nov 240.13
Nov 240.17
Oct 240.17
Inovalis Real Estate Investment Trust
IVREF
Stockpicker

Video analysis: IVREF

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: IVREF

Inovalis Real Estate Investment Trust (OTCMKTS:IVREF) & Empire State Realty Trust (NYSE:ESRT) Financial Analysis

defenseworld.net · 14 Aug 2026

Inovalis Real Estate Investment Trust (OTCMKTS:IVREF) & Empire State Realty Trust (NYSE:ESRT) Financial Analysis

Empire State Realty Trust (NYSE: ESRT - Get Free Report) and Inovalis Real Estate Investment Trust (OTCMKTS:IVREF - Get Free Report) are both real estate companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, profitability, valuation, analyst recommendations, dividends, earnings and risk. Analyst Recommendations

Reviewing Orion Office REIT (NYSE:ONL) and Inovalis Real Estate Investment Trust (OTCMKTS:IVREF)

defenseworld.net · 12 Aug 2026

Reviewing Orion Office REIT (NYSE:ONL) and Inovalis Real Estate Investment Trust (OTCMKTS:IVREF)

Inovalis Real Estate Investment Trust (OTCMKTS:IVREF - Get Free Report) and Orion Office REIT (NYSE: ONL - Get Free Report) are both real estate companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, dividends, analyst recommendations, profitability, earnings and valuation. Earnings and Valuation

Inovalis Real Estate Investment Trust Announces the Financial Results for Q2 2026

businesswire.com · 6 Aug 2026

Inovalis Real Estate Investment Trust Announces the Financial Results for Q2 2026

TORONTO--(BUSINESS WIRE)--Inovalis Real Estate Investment Trust (the “REIT”) (TSX: INO.UN) today reported financial results for the quarter ended June 30, 2026. The unaudited Consolidated Financial Statements and Management's Discussion and Analysis ("MD&A") for Q2 2026 and 2025 are available on the REIT's website at www.inovalisreit.com and at www.sedarplus.ca. All amounts except rental rates, square footage and per unit amounts are presented in thousands of Canadian dollars or Euros, or a.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.